Cart
sales@molnova.com
Home -
Products -
PI3K/Akt/mTOR signaling -
PDK -
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
CAS No. 1207836-10-9
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile( —— )
Catalog No. M37049 CAS No. 1207836-10-9
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 26 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
-
NoteResearch use only, not for human use.
-
Brief Description6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
-
Description6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPDK
-
RecptorPDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1207836-10-9
-
Formula Weight252.07
-
Molecular FormulaC9H6BrN3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(Br)cn2ncc(C#N)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Clodronate Disodium
Clodronate Disodium, a bisphosphonate, is a potent antiosteolytic agent which inhibits bone resorption.
-
PDK1 inhibitor 7
A potent, selective PDK1 inhibitor with IC50 of 1 nM.
-
KPLH1130
KPLH1130 improves glucose tolerance in HFD-fed mice.?KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.
